A TechAdvance award of $92,000 has been granted to a team led by David Shreiber. The funding, which is through the Rutgers Office of Research and Economic Development, is to develop a biomaterial technology for targeted drug delivery.
A TechAdvance award of $92,000 has been granted to a team led by David Shreiber. The funding, which is through the Rutgers Office of Research and Economic Development, is to develop a biomaterial technology for targeted drug delivery.